Table 1 PSMA expression in the microvessels of thyroid tumors.
From: PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
Total | PSMA +ve | mean PSMA | Low PSMA (5–50%) | High PSMA (>50%) | ||||
|---|---|---|---|---|---|---|---|---|
n | n | % | proportion score | n | %* | n | %* | |
Follicular adenoma | 43 | 8 | 19% | 3.7 | 8 | 100% | 0 | 0% |
Non-oncocytic | 32 | 7 | 22% | 5.3 | 7 | 100% | 0 | 0% |
Oncocytic | 11 | 1 | 9% | 1.3 | 1 | 100% | 0 | 0% |
Follicular thyroid carcinoma | 52 | 24 | 46% | 10.6 | 19 | 79% | 5 | 21% |
Non-oncocytic | 35 | 20 | 57% | 11.6 | 16 | 80% | 4 | 20% |
Oncocytic | 17 | 4 | 24% | 7.4 | 3 | 75% | 1 | 25% |
Papillary thyroid carcinoma | 120 | 61 | 51% | 24.7 | 33 | 54% | 28 | 46% |
Classic variant | 49 | 29 | 59% | 30.0 | 12 | 41% | 17 | 59% |
Follicular variant | 33 | 12 | 36% | 13.7 | 6 | 50% | 6 | 50% |
Tall cell variant | 5 | 4 | 80% | 44.4 | 2 | 50% | 2 | 50% |
Microcarcinoma | 9 | 3 | 33% | 16.0 | 2 | 67% | 1 | 33% |
Lymph node metastasis | 24 | 13 | 54% | 11.6 | 11 | 85% | 2 | 15% |
RAI-refractory carcinoma | 24 | 15 | 63% | 32.5 | 8 | 53% | 7 | 47% |
Poorly differentiated carcinoma | 8 | 4 | 50% | 37.0 | 2 | 50% | 2 | 50% |
Anaplastic thyroid carcinoma | 10 | 4 | 40% | 21.0 | 1 | 25% | 3 | 75% |
Medullary thyroid carcinoma | 10 | 4 | 40% | 13.7 | 3 | 75% | 1 | 25% |
Total | 267 | 120 | 45% | 17.9 | 74 | 62% | 46 | 38% |
